We harness the potential of medicinal cannabis

Swiss Made

MediCrops Holding AG - The Future of Pharma

THC as medicine

Play Video

Sustainable cultivation

Medicinal THC offers a wide range of health benefits. Sustainability takes centre stage with us.

Professional processing

Our preparations are produced in accordance with the most stringent quality guidelines.

Fast and secure distribution

The prompt supply of our partners in the healthcare sector is always guaranteed.

For prospective investors

Medical THC is one of the markets of the future in the pharmaceutical sector and MediCrops® covers the entire value chain, from cultivation to finished processing. Strarting from CHF 50,000 investors can participate in the growth of MediCrops®. Detailed information can be found in the comprehensive documentation.

The future of pain treatment begins now

Learn more about Medicrops

Über Medicrops

Company

MediCrops Holding AG – a Swiss pharmaceutical company that holds high Swiss values.

key_10

THC as a medicine

The health benefits of medicinal THC preparations in the spotlight.

Labor3

Your career

We collaborate with top-notch research institutions and specialists. Are you one of them?

news-header

News

Here you can find the very latest information, trends and developments in the market for medicinal THC.

Investoren

Investors

Invest in the future of the THC market – and thus in the future of medicine.

key-7

Patienteninformationen

Sie leiden unter chronischen Schmerzen? Hier finden Sie alles Wissenswerte zu den verschiedene Präparaten.